Germany Optogenetics Market Analysis

Germany Optogenetics Market Analysis


$ 3999

Germany optogenetics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in the prevalence of neurological illnesses, the rise in optogenetics R&D activities, and the rise in demand for neuroscience research are all contributing factors to the expansion of the optogenetics market. Some of the major key players in this market are Cobalt, Coherent Inc., Gensight Biologics, Laserglow Technologies, Noldus Information Technology, etc.

ID: IN10DEPH348 CATEGORY: Pharmaceuticals GEOGRAPHY: Germany AUTHOR: Riddhi Solanki

Buy Now

Germany Optogenetics Market Analysis Summary

Germany Optogenetics Market is valued at around $1176.4 Mn in 2022 and is projected to reach $3864.8 Mn by 2030, exhibiting a CAGR of 16.03% during the forecast period 2023-2030.

A cutting-edge method called optogenetics combines genetics and optics to allow for the precise control of certain neurons in living things. By enabling scientists to selectively activate or inhibit neurons with extraordinary precision and temporal resolution, it has revolutionized the study of neuroscience. Utilizing opsins, which are light-sensitive proteins generated from microorganisms like bacteria or algae, is the fundamental tenet of optogenetics. These opsins can be genetically modified to express particular kinds of neurons, making those neurons light-sensitive. The rise in the prevalence of neurological illnesses, the rise in optogenetics R&D activities, and the rise in demand for neuroscience research are all contributing factors to the expansion of the optogenetics market. The major key players in this market are Cobalt, Coherent Inc., Gensight Biologics, Laserglow Technologies, Noldus Information Technology, Scientifica, Shanghai Laser & Optics Century Co. Ltd., Jackson Laboratory, Thorlabs Inc., Thomas RECORDING GmbH, UNC Vector Core, Addgene, and Elliot Scientific Ltd.

Market Dynamics

Market Growth Drivers

More than 5 million Americans have Alzheimer's disease, and an estimated 16 million are looking for unpaid care, according to a July 2020 report by the Alzheimer's Impact Movement. In 2020, the US would spend $305 Bn on Alzheimer's disease, of which $206 Bn will come from Medicare and Medicaid payments. The expanding patient population needs more care, which raises the demand for optogenetics and quickens market expansion. Another element influencing market expansion is partnerships and agreements. For instance, NeuroLux Inc. announced in September 2021 an exclusive partnership with TSE Systems to integrate its wireless technology with TSE Systems' IntelliCage and PhenoMaster platforms, supplying optogenetic, pharmacology, telemetry, and other capabilities for cutting-edge behavioral neuroscience research.

Market Restraints

Optogenetics market expansion will be hampered by the fact that developing economies are less familiar with it than developed economies are.

Competitive Landscape

Key Players

  • Cobalt
  • Coherent Inc.
  • Gensight Biologics
  • Laserglow Technologies
  • Noldus Information Technology
  • Scientifica
  • Shanghai Laser & Optics Century Co. Ltd.
  • Jackson Laboratory
  • Thorlabs Inc.
  • Thomas RECORDING GmbH
  • UNC Vector Core
  • Addgene
  • Elliot Scientific Ltd.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Germany Optogenetics Market Segmentation

By Light Equipment Type

  • Laser
  • Light-emitting Diode (LED)

By Actuator

  • Channelrhodopsin
  • Halorhodopsin
  • Archaerhodopsin

By Sensor

  • Calcium Aequorin
  • Cameleon
  • Other
  • pH Sensors
  • Genetically Modified Calcium Indicators
  • Neurotransmitter Release
  • Voltage-sensitive Fluorescent Proteins
  • Chloride (Clomeleon)
  • Membrane-gated (Mermaid)

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Dr. Purav Gandhi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up